查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1649440

沙門氏菌檢測與治療市場 - 2025 年至 2030 年預測

Salmonella Testing and Treatment Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

沙門氏菌檢測和治療市場預計將以 6.28% 的複合年成長率成長，從 2025 年的 22.36 億美元成長到 2030 年的 30.32 億美元。

沙門氏菌是一種會引起食物中毒的細菌，可感染人類和動物。它感染多種動物並引起家禽、牛和豬的多種疾病。主要感染途徑包括受污染的食物、水、交叉污染和表面，也可導致人類感染。沙門氏菌引起的常見疾病包括食物中毒、傷寒、沙門氏菌病、副傷寒、沙門氏菌腦膜炎和肺炎。確保食品安全對於防止沙門氏菌的傳播至關重要。受污染的食物和飲料是沙門氏菌感染最常見的媒介。這就是為什麼乳製品、加工食品、肉類和蛋類等食品在到達消費者手中之前必須經過嚴格的沙門氏菌檢測。對牛肉和豬肉等肉類進行檢測和診斷對於維護食品安全和防止沙門氏菌爆發至關重要。因此，沙門氏菌檢測和治療對於保護公眾健康和確保安全消費至關重要。傷寒和副傷寒患者需要診斷測試和適當的治療，這大大增加了沙門氏菌檢測和治療市場的需求。沙門氏菌爆發的不斷增加導致食物中毒和傷寒等相關疾病的增加。這一趨勢推動了對沙門氏菌診斷和治療的需求，沙門氏菌不僅可以感染人類，還可以感染家禽等動物。沙門氏菌感染疾病數量的不斷增加凸顯了採取有效措施遏制病毒傳播、確保公共衛生安全的必要性。針對此，世界各國政府正在實施更嚴格的法規，並投資於檢測和治療解決方案，進一步推動市場成長。此外，加強對食品安全的關注對於防止沙門氏菌爆發至關重要。檢測和治療診斷技術的進步也推動了市場的成長。

沙門氏菌檢測和治療市場促進因素：

  • 有關沙門氏菌檢測的政府法規趨勢：全球範圍內越來越多的政府法規要求食品製造商在將乳製品和加工食品等產品出售給消費者之前對其進行沙門氏菌檢測。由於沙門氏菌疫情的增多，監管力度的加強促使各國政府在食品和飲料業實施更嚴格的預防措施。例如，美國食品藥物管理局（FDA）為生產、加工、包裝或保存人類食品的公司提供了指南，強調了沙門氏菌檢測的重要性。這包括解釋測試結果並在檢測到污染時採取適當的措施。這些法規迫使食品製造商（包括家禽、肉類和牛肉產業）進行沙門氏菌檢測，推動市場成長。

影響沙門氏菌檢測和治療市場的地理趨勢：

  • 亞太地區是成長最快的地區：全球沙門氏菌檢測和治療市場分為北美、南美、歐洲、中東和非洲以及亞太地區等地區。預計預測期內北美將繼續主導市場，而亞太地區預計將以最快的速度成長。

亞太地區的快速成長得益於中國、韓國和印度等新興經濟體加強其醫療保健基礎設施。這一發展導致對沙門氏菌檢測和治療服務的需求增加。此外，這些國家不斷加強的食品安全法規也進一步推動了市場的成長。食品加工設施的增加需要嚴格的食品安全標準，從而推動對有效的沙門氏菌檢測解決方案的需求。此外，神經系統疾病的增加也推動了該地區對診斷的需求。另一方面，由於食源性疾病發生率高，加上法規結構嚴格且醫療保健行業強大，預計北美將佔據市場主要佔有率。美國等國家的先進醫療基礎設施支持有效的沙門氏菌治療實踐。總之，隨著相關人員尋求有效的解決方案來對抗這種普遍的健康威脅，嚴格的政府法規和不斷提高的食品安全意識等區域動態正在推動全球沙門氏菌檢測和治療市場的成長。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興區域，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 適合廣泛用戶：對於新興企業、科學研究機構、顧問公司、中小企業和大型企業來說都是有益且具成本效益的。

它有什麼用途？

產業與市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的歷史資料與預測
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測分析包括國家在內的細分市場和地區
  • 公司概況（尤其是主要趨勢）

沙門氏菌檢測和治療市場細分如下：

按檢驗方法

  • 基於文化的方法
  • 基於分子的方法
  • 免疫檢測

依治療方法

  • 抗生素治療
  • 支持治療
  • 疫苗接種
  • 其他

按最終用途

  • 食品工業
  • 衛生保健
  • 農業和畜牧業
  • 其他

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 其他
  • 中東/非洲 沙烏地阿拉伯 阿根廷 其他中東/非洲
  • 沙烏地阿拉伯
  • UAE
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 韓國
  • 澳洲
  • 印度
  • 印尼
  • 泰國
  • 其他

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

5. 沙門氏菌檢測與治療市場（依檢測方法分類）

  • 介紹
  • 基於文化的方法
  • 基於分子的方法
  • 免疫檢測

6. 沙門氏菌檢測與治療市場（依治療方法）

  • 介紹
  • 抗生素治療
  • 支持治療
  • 接種疫苗
  • 其他

7. 沙門氏菌檢測和治療市場（依最終用途）

  • 介紹
  • 食品工業
  • 衛生保健
  • 農業和畜牧業
  • 其他

8. 沙門氏菌檢測與治療市場（按地區）

  • 介紹
  • 北美洲
    • 按檢驗方法
    • 依治療方法
    • 按最終用途
    • 按國家
  • 南美洲
    • 按檢驗方法
    • 依治療方法
    • 按最終用途
    • 按國家
  • 歐洲
    • 按檢驗方法
    • 依治療方法
    • 按最終用途
    • 按國家
  • 中東和非洲
    • 按檢驗方法
    • 依治療方法
    • 按最終用途
    • 按國家
  • 亞太地區
    • 按檢驗方法
    • 依治療方法
    • 按最終用途
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Gold Standard Diagnostics
  • Romer Labs
  • BD
  • Pfizer Inc.
  • Agilent Technologies Inc.
  • Eurofins Scientific
  • QIAGEN
  • Bio-Rad Laboratories Inc.
簡介目錄
Product Code: KSI061617249

The salmonella testing and treatment market is expected to grow at a CAGR of 6.28%, reaching a market size of US$3.032 billion in 2030 from US$2.236 billion in 2025

Salmonella is a type of bacteria responsible for food poisoning and infections in both humans and animals. It can affect a wide range of animals, leading to various diseases in poultry, cattle, and pigs. The primary transmission routes include contaminated food, water, cross-contamination, and surfaces, which can also lead to human infections. Common illnesses caused by Salmonella include foodborne illnesses, typhoid fever, salmonellosis, paratyphoid fever, salmonella meningitis, and pneumonia.Ensuring food safety is crucial to preventing the spread of Salmonella. Contaminated foods and beverages are the most common transmission vectors for these bacteria. Therefore, rigorous salmonella testing is essential for food products such as dairy, processed foods, meats, and eggs before they reach consumers. Testing and diagnosing meats like beef and pork is vital for maintaining food safety and preventing outbreaks of salmonella. Consequently, salmonella testing and treatment are critical for protecting public health and ensuring safe consumption. Individuals affected by typhoid or paratyphoid require diagnostic testing and appropriate treatment, which significantly contributes to the demand within the salmonella testing and treatment market.The increasing incidence of salmonella outbreaks has led to a rise in related diseases among people, including foodborne illnesses and typhoid fever. This trend drives the demand for diagnosis and treatment not only in humans but also in animals such as poultry, which can also transmit the disease. The growing number of salmonella outbreaks emphasizes the need for effective measures to stop its spread and ensure public health safety. In response, governments are implementing stricter regulations and investing in testing and treatment solutions, further propelling market growth. Additionally, heightened focus on food safety is essential for preventing salmonella outbreaks. Advances in diagnostic techniques for testing and treatment are also significantly boosting market growth.

Drivers of the Salmonella Testing and Treatment Market:

  • Increasing Government Regulations for Salmonella Testing: There is a growing trend of government regulations worldwide mandating food manufacturers to conduct salmonella testing on their products-such as dairy items and processed foods-before they are sold to consumers. These regulations have tightened due to the rising number of salmonella outbreaks, prompting governments to enforce stricter preventive measures in the food and beverage sector. For example, the U.S. Food and Drug Administration (FDA) provides guidelines for companies involved in manufacturing, processing, packing, or holding human foods that emphasize the importance of salmonella testing. This includes interpreting test results and taking appropriate actions if contamination is detected. Such regulations compel food manufacturers-including those in poultry, meat, and beef sectors-to conduct salmonella testing, thereby driving market growth.

Geographical Trends Shaping the Salmonella Testing and Treatment Market:

  • Asia-Pacific as the Fastest-Growing Region: The global salmonella testing and treatment market is segmented into regions including North America, South America, Europe, the Middle East and Africa, and Asia Pacific. During the forecast period, Asia Pacific is expected to be the fastest-growing region while North America will continue to dominate the market.

The rapid growth in Asia Pacific is driven by emerging economies like China, South Korea, and India that are enhancing their healthcare infrastructure. This development increases the demand for salmonella testing and treatment services. Additionally, growing food safety regulations in these countries further accelerate market growth. The rise in food processing units necessitates stringent food safety standards and increases the need for effective salmonella testing solutions. Furthermore, an increase in neurological disorders is driving demand for diagnostics in this region.Meanwhile, North America is projected to maintain a significant share of the market due to high rates of foodborne illnesses coupled with strict regulatory frameworks and a robust healthcare sector. The advanced healthcare infrastructure in countries like the United States supports efficient salmonella treatment practices.In summary, both regional dynamics-such as stringent government regulations-and increasing awareness about food safety are driving growth in the global salmonella testing and treatment market as stakeholders seek effective solutions to combat this pervasive health threat.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Salmonella Testing and Treatment Market has been segmented as following:

By Testing Method

  • Culture-based Methods
  • Molecular-based Methods
  • Immunoassay

By Treatment Method

  • Antibiotic Treatment
  • Supportive Care
  • Vaccination
  • Others

By End-User

  • Food Industry
  • Healthcare
  • Agriculture and Animal Husbandry
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Australia
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. SALMONELLA TESTING AND TREATMENT MARKET BY TESTING METHOD

  • 5.1. Introduction
  • 5.2. Culture-based Methods
  • 5.3. Molecular-based Methods
  • 5.4. Immunoassay

6. SALMONELLA TESTING AND TREATMENT MARKET BY TREATMENT METHOD

  • 6.1. Introduction
  • 6.2. Antibiotic Treatment
  • 6.3. Supportive Care
  • 6.4. Vaccination
  • 6.5. Others

7. SALMONELLA TESTING AND TREATMENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Food Industry
  • 7.3. Healthcare
  • 7.4. Agriculture and Animal Husbandry
  • 7.5. Others

8. SALMONELLA TESTING AND TREATMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Testing Method
    • 8.2.2. By Treatment Method
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Testing Method
    • 8.3.2. By Treatment Method
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Testing Method
    • 8.4.2. By Treatment Method
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Testing Method
    • 8.5.2. By Treatment Method
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Testing Method
    • 8.6.2. By Treatment Method
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. Australia
      • 8.6.4.5. India
      • 8.6.4.6. Indonesia
      • 8.6.4.7. Thailand
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Thermo Fisher Scientific Inc.
  • 10.2. Merck KGaA
  • 10.3. Gold Standard Diagnostics
  • 10.4. Romer Labs
  • 10.5. BD
  • 10.6. Pfizer Inc.
  • 10.7. Agilent Technologies Inc.
  • 10.8. Eurofins Scientific
  • 10.9. QIAGEN
  • 10.10. Bio-Rad Laboratories Inc.